Cosmegen Lyovac

Cosmegen Lyovac


Project Description

Active Ingredient: Dactinomycin 500mcg

Dosage Form: Lyophilised powder for solution for injection

Indication:

  • As a single agent or as a part of combination chemotherapy and/or multi-modality treatment regimen for Wilms’ tumor, childhood rhabdomyosarcoma, Ewing’s sarcoma, and metastatic nonseminomatous testicular cancer, gestational trophoblastic neoplasia.
  • Treatment of locally recurrent or locoregionally metastatic melanoma in combination with Mephalan

Packaging: Box of 1 vials

Manufacturer: Baxter Oncology GmbH – Germany

MAH: Orphan Europe SARL – France